Reaction
Oral Mucosal Erythema reporting signals
As of the last recalculation, Oral Mucosal Erythema appears in 1,526 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is RIZATRIPTAN BENZOATE (PRR 14.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Rizatriptan Benzoate | 11 | 14.8 | 14.9 |
| Sunitinib Malate | 27 | 9.5 | 9.5 |
| Minocycline | 8 | 9.4 | 9.4 |
| Alpelisib | 5 | 7.8 | 7.9 |
| Nicotine Polacrilex | 19 | 6.8 | 6.8 |
| Buprenorphine Hydrochloride, Naloxone Hydrochloride | 12 | 6.8 | 6.8 |
| Asenapine Maleate | 4 | 6.3 | 6.3 |
| Cabozantinib | 21 | 6.0 | 6.0 |
| Regorafenib | 5 | 5.9 | 5.9 |
| Pazopanib Hydrochloride | 10 | 5.1 | 5.1 |
| Lifitegrast | 4 | 3.3 | 3.3 |
| Tapentadol Hydrochloride | 7 | 2.9 | 2.9 |
| Nirmatrelvir And Ritonavir | 7 | 1.8 | 1.8 |